![]() |
市場調查報告書
商品編碼
1300100
大腸癌(CRC)篩檢的全球市場(2023年版):各篩檢類型,各最終用途,各地區,各國分析,市場考察,預測(2019年~2029年)Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By Region, By Country: Market Insights and Forecast (2019-2029) |
全球大腸癌(CRC)篩檢的市場規模將從2022年的172億美元達到2029年的277億美元,在預測期間(2024年~2029年)時預計將以年複合成長率7%的速度成長。可支配所得的增加,都市化,不健康的生活方式等要素,促進了大腸癌(CRC)篩檢的需求。
本報告提供全球大腸癌(CRC)篩檢市場相關調查,提供市場規模與預測,地區和市場區隔的分析,主要趨勢和機會等資訊。
Azoth Analytics has released a research named "Global Colorectal Cancer (CRC) Screening Market (2023 Edition)" which provides a complete analysis of the global Colorectal Cancer (CRC) Screening industry in terms of segmentation by Screening Type (Stool-based Tests, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography - Virtual Colonoscopy, Other Screening Type), By End-use (Hospitals & Clinics, Clinical Laboratories, Diagnostic Imaging Centers) for the historical period of 2019-2022, estimated year of 2023 and the forecast period of 2024-2029.
The research is global in nature and covers a detailed analysis of the market in America (U.S., Canada, Brazil, Rest of Americas), Europe (Germany, U.K., France, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Rest of Asia-Pacific), and Middle-east and Africa. Additionally, the research report displays data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
During the forecast period, 2024-2029, the global Colorectal Cancer (CRC) Screening market is expected to expand at a CAGR of 7%. Ageing populations, rising CRC incidence with age, preference for healthy living, increased awareness of the severity of cancers, rising bowel cancer incidence, rising prevalence of disease, and increased government policies for CRC screening in an effort to reduce diseases globally are some of the key factors influencing demand for colorectal cancer screening globally.
The Global Colorectal Cancer (CRC) Screening Market is expected to generate USD 27.7 billion by the end of 2029, up from USD 17.2 billion in 2022. Some of the key factors driving demand for Colorectal Cancer (CRC) Screening globally include rising disposable incomes, urbanization, an unhealth lifestyle, westernization, a preference for leading healthy lifestyles, increased consumer awareness of the severity of digestive disorders, stomach pain, willingness to pay a high price for cancer screening and treatment, and market accessibility of various screening & tests.
Additionally, Colorectal Cancer (CRC) Screening sales are being positively boosted by enhanced new product development and strong promotional actions by key manufacturers & diagnostic labs. The rising prevalence of colorectal cancer is one of the major factors driving the market growth. Some other factors include for the growth of the colorectal cancer screening the advent of efficacious genetic tests, an increase in the prevalence of colorectal cancer, and increasing cancer prevention initiatives.
One of the main drivers fueling the Colorectal Cancer Screening Market; the increasing incidence of colorectal cancer. An estimated 1,019,000 new instances of cancer, including 158,200 new cases of colorectal cancer, were expected in Japan in 2022, according to data offered by the National Cancer Centre Japan in June 2022. Similar to this, it was estimated that 15,713 new cases of colorectal cancer would be identified in Australia in 2022, out of which 8,300 were male and 7,413 were female, according to data updated by Cancer Australia in August 2022.
Colonoscopy is one of the most common procedures performed, with about 14.2 million procedures carried out alone in the United States. Data on national trends imply an increase in CRC screening rates, which is nearly completely related to more people having colonoscopies. Therefore, it is expected that the use of colonoscopy (CRC Screening) equipment will increase as colorectal cancer rates rise.
Companies in the Colorectal Cancer (CRC) Screening market are placing stakes on R&D investments and new product releases as patient become more aware about cancer and innovative trends emerge quickly. Companies are paying close attention to value-added offerings as long as healthcare specialists continue to recommend increasing the screening tests as a way to go for the better treatment and improve long-term health. The potential of Colorectal Cancer (CRC) Screenings in products is being systematically investigated by large brand firms as well as small high-tech startups, which may signal new beginnings for market players.
The study profiles leading players in the Global Colorectal Cancer (CRC) Screening Market including Olympus Corporation, EXACT Sciences Corporation, Quest Diagnostics, QuidelOrtho Corporation, Fujifilm Holdings Corporation, Eiken Chemical Co. Ltd, BioMerieux SA, Epigenomics AG, Siemens Healthineers, Danaher Corporation, and others. The company profiling includes critical information such as a business overview, products and services, key financials, and recent events and developments. Overall, the report provides a detailed overview of the Global Colorectal Cancer (CRC) Screening Market, which will assist industry consultants, medical equipment manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders in aligning their market-centric strategies with current and expected future trends.
Scope of the Report:
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include are Olympus Corporation, EXACT Sciences Corporation, Quest Diagnostics, QuidelOrtho Corporation, Fujifilm Holdings Corporation, Eiken Chemical Co. Ltd, BioMerieux SA, Epigenomics AG, Siemens Healthineers, Danaher Corporation.
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: Estimated Worldwide Epidemiology of Colorectal Cancer, 2018
Table A3: Colorectum Cancer incidence and mortality statistics worldwide and by region
Table A4: United States Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A5: United States Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A6: United States Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A7: United States Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A8: Canada Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A9: Canada Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A10: Canada Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A11: Canada Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A12: Brazil Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A13: Brazil Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A14: Brazil Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A15: Brazil Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A16: Rest of Americas Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A17: Rest of Americas Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A18: Rest of Americas Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A19: Rest of Americas Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A20: Germany Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A21: Germany Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A22: Germany Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A23: Germany Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A24: United Kingdom Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A25: United Kingdom Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A26: United Kingdom Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A27: United Kingdom Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A28: France Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A29: France Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A30: France Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A31: France Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A32: Rest of Europe Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A33: Rest of Europe Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A34: Rest of Europe Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A35: Rest of Europe Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A36: China Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A37: China Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A38: China Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A39: China Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A40: Japan Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A41: Japan Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A42: Japan Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A43: Japan Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A44: India Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A45: India Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A46: India Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A47: India Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A48: South Korea Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A49: South Korea Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A50: South Korea Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A51: South Korea Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A52: Rest of Asia-Pacific Colorectal Cancer Screening Market, By Screening Type, By Value, 2019-2022 (USD Million)
Table A53: Rest of Asia-Pacific Colorectal Cancer Screening Market, By Screening Type, By Value, 2024-2029 (USD Million)
Table A54: Rest of Asia-Pacific Colorectal Cancer Screening Market, By End-use, By Value, 2019-2022 (USD Million)
Table A55: Rest of Asia-Pacific Colorectal Cancer Screening Market, By End-use, By Value, 2024-2029 (USD Million)
Table A56: Olympus Corporation Financials, 2020-2022
Table A57: Exact Sciences Corp. Financials, 2020-2022
Table A58: Quest Diagnostics Financials, 2020-2022
Table A59: QuidelOrtho Corporation Financials, 2020-2022
Table A60: BioMerieux SA Financials, 2020-2022
Table A61: Fujifilm Holdings Corporation Financials, 2020-2022
Table A62: Eiken Chemical Co. Ltd Financials, 2020-2022
Table A63: Epigenomics AG Financials, 2020-2022
Table A64: Siemens Healthineers Financials, 2020-2022
Table A65: Danaher Corporation Financials, 2020-2022